PCLOF
Price
$0.04
Change
-$0.00 (-0.00%)
Updated
Sep 5 closing price
Capitalization
5.94M
ROMJF
Price
$0.44
Change
-$0.02 (-4.35%)
Updated
Sep 5 closing price
Capitalization
28.73M
Interact to see
Advertisement

PCLOF vs ROMJF

Header iconPCLOF vs ROMJF Comparison
Open Charts PCLOF vs ROMJFBanner chart's image
PHARMACIELO
Price$0.04
Change-$0.00 (-0.00%)
Volume$10K
Capitalization5.94M
Rubicon Organics
Price$0.44
Change-$0.02 (-4.35%)
Volume$24.6K
Capitalization28.73M
PCLOF vs ROMJF Comparison Chart in %
Loading...
PCLOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROMJF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PCLOF vs. ROMJF commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PCLOF is a StrongBuy and ROMJF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (PCLOF: $0.04 vs. ROMJF: $0.44)
Brand notoriety: PCLOF and ROMJF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: PCLOF: 20% vs. ROMJF: 51%
Market capitalization -- PCLOF: $5.94M vs. ROMJF: $28.73M
PCLOF [@Pharmaceuticals: Generic] is valued at $5.94M. ROMJF’s [@Pharmaceuticals: Generic] market capitalization is $28.73M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.94B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PCLOF’s FA Score shows that 0 FA rating(s) are green whileROMJF’s FA Score has 0 green FA rating(s).

  • PCLOF’s FA Score: 0 green, 5 red.
  • ROMJF’s FA Score: 0 green, 5 red.
According to our system of comparison, ROMJF is a better buy in the long-term than PCLOF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PCLOF’s TA Score shows that 4 TA indicator(s) are bullish while ROMJF’s TA Score has 2 bullish TA indicator(s).

  • PCLOF’s TA Score: 4 bullish, 3 bearish.
  • ROMJF’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, PCLOF is a better buy in the short-term than ROMJF.

Price Growth

PCLOF (@Pharmaceuticals: Generic) experienced а +89.81% price change this week, while ROMJF (@Pharmaceuticals: Generic) price change was -9.76% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.10%. For the same industry, the average monthly price growth was +12.13%, and the average quarterly price growth was +87.01%.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.10% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ROMJF($28.7M) has a higher market cap than PCLOF($5.94M). ROMJF YTD gains are higher at: 34.016 vs. PCLOF (-21.372). ROMJF has higher annual earnings (EBITDA): 3.31M vs. PCLOF (-4.6M). ROMJF has more cash in the bank: 7.78M vs. PCLOF (148K). ROMJF has less debt than PCLOF: ROMJF (9.7M) vs PCLOF (20.5M). ROMJF has higher revenues than PCLOF: ROMJF (52.2M) vs PCLOF (3.48M).
PCLOFROMJFPCLOF / ROMJF
Capitalization5.94M28.7M21%
EBITDA-4.6M3.31M-139%
Gain YTD-21.37234.016-63%
P/E RatioN/A60.49-
Revenue3.48M52.2M7%
Total Cash148K7.78M2%
Total Debt20.5M9.7M211%
FUNDAMENTALS RATINGS
PCLOF vs ROMJF: Fundamental Ratings
PCLOF
ROMJF
OUTLOOK RATING
1..100
596
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
70
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9992
PRICE GROWTH RATING
1..100
5139
P/E GROWTH RATING
1..100
10045
SEASONALITY SCORE
1..100
509

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PCLOF's Valuation (60) in the null industry is in the same range as ROMJF (70). This means that PCLOF’s stock grew similarly to ROMJF’s over the last 12 months.

PCLOF's Profit vs Risk Rating (100) in the null industry is in the same range as ROMJF (100). This means that PCLOF’s stock grew similarly to ROMJF’s over the last 12 months.

ROMJF's SMR Rating (92) in the null industry is in the same range as PCLOF (99). This means that ROMJF’s stock grew similarly to PCLOF’s over the last 12 months.

ROMJF's Price Growth Rating (39) in the null industry is in the same range as PCLOF (51). This means that ROMJF’s stock grew similarly to PCLOF’s over the last 12 months.

ROMJF's P/E Growth Rating (45) in the null industry is somewhat better than the same rating for PCLOF (100). This means that ROMJF’s stock grew somewhat faster than PCLOF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PCLOFROMJF
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
81%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
77%
Bearish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
67%
Advances
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 4 days ago
71%
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 1 day ago
82%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
81%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
65%
View a ticker or compare two or three
Interact to see
Advertisement
PCLOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROMJF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RETO1.840.24
+14.70%
ReTo Eco-Solutions Inc
SIFY11.170.94
+9.14%
Sify Technologies Ltd
CLYM2.390.06
+2.58%
Climb Bio Inc
NTR56.43-0.55
-0.97%
Nutrien Ltd
CXT61.10-0.62
-1.00%
Crane NXT Co

PCLOF and

Correlation & Price change

A.I.dvisor tells us that PCLOF and OWPC have been poorly correlated (+8% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PCLOF and OWPC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PCLOF
1D Price
Change %
PCLOF100%
+5.13%
OWPC - PCLOF
8%
Poorly correlated
-0.25%
PHCUF - PCLOF
7%
Poorly correlated
N/A
RGEDF - PCLOF
5%
Poorly correlated
N/A
OVATF - PCLOF
4%
Poorly correlated
N/A
ROMJF - PCLOF
3%
Poorly correlated
-4.79%
More

ROMJF and

Correlation & Price change

A.I.dvisor tells us that ROMJF and SGIOF have been poorly correlated (+8% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ROMJF and SGIOF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROMJF
1D Price
Change %
ROMJF100%
-4.79%
SGIOF - ROMJF
8%
Poorly correlated
N/A
SGIOY - ROMJF
8%
Poorly correlated
+2.98%
RSCI - ROMJF
5%
Poorly correlated
N/A
TEVJF - ROMJF
4%
Poorly correlated
N/A
PCLOF - ROMJF
3%
Poorly correlated
+5.13%
More